Tobamovirus Cross Protection Using a Potexvirus Vector  by Culver, James N.
VIROLOGY 226, 228–235 (1996)
ARTICLE NO. 0650
Tobamovirus Cross Protection Using a Potexvirus Vector
JAMES N. CULVER
Center for Agricultural Biotechnology, University of Maryland Biotechnology Institute, College Park, Maryland 20742
Received June 3, 1996; accepted October 8, 1996
Cross protection is the ability of one virus to prevent or delay infection by a related challenge virus. To examine this
phenomena, a potato X potexvirus (PVX) vector (Chapman et al., 1992, Plant J. 2, 549) was used to systemically express
the tobacco mosaic tobamovirus (TMV) coat protein (CP) open reading frame in Nicotiana benthamiana. PVX constructs
induce mild mosaic symptoms in N. benthamiana, whereas TMV infection results in rapid systemic necrosis and plant death.
Healthy plants or plants preinfected with the unmodified PVX vector succumbed to necrosis within 1 week of TMV challenge
inoculation. However, plants preinfected with PVX vectors expressing the TMV CP or RNA coding sequence displayed a 1-
to 2-week delay in the appearance of TMV-induced necrosis along with reduced accumulations of TMV. Symptom delay
and reductions in the accumulation of TMV were more pronounced in plants protected with the vector expressing the TMV
CP than with the vector expressing a nontranslatable CP sequence. Protection was overcome more quickly using a 10-fold
higher concentration of challenge inoculum and was ineffective against TMV RNA or a TMV construct expressing a distantly
related tobamovirus CP. These findings demonstrate that both RNA and protein are involved in this cross protection
phenomenon, but that CP is the main contributor to protection. Taken together, these studies indicate that virus vectors
can be used to simulate both cross protection and transgene-derived coat protein-mediated protection, thus providing a
new method to further investigate the mechanisms behind each. q 1996 Academic Press, Inc.
INTRODUCTION a necrotizing strain of TMV (Fulton, 1951; Sherwood and
Fulton, 1982). Such dark green areas contain lower levels
Cross protection is the ability of one virus to inhibit or of virus than are found in light green mosaic areas (de-
prevent infection by a second virus (Dodds, 1982). In Zoeten and Gaard, 1984). This indicates that the pres-
general, the virus conferring protection (the protecting ence of the protecting strain is required for resistance.
virus) must be established in the plant prior to inoculation However, the selective difference between light and dark
with the second virus (the challenge virus). Protection green areas can be overcome by using unencapsidated
is also limited to closely related viruses. A number of viral RNA as inoculum (Sherwood and Fulton, 1982).
mechanisms have been proposed to explain this phe- Based on this evidence it has been proposed that cross
nomena including: (1) the coat protein (CP) of the pro- protection between TMV strains is the result of the pro-
tecting virus acts to encapsidate challenge virus RNA tecting virus preventing the challenge virus from uncoat-
preventing its expression, (2) RNA from the protecting ing (Sherwood and Fulton, 1982). Sherwood (1987b) also
virus hybridizes with nascent RNA of the challenge virus, determined that a CP-free strain of TMV, DT-1G (Sarkar
(3) the protecting virus prevents the systemic movement and Smitamana, 1981), did not confer protection in N.
of the challenge virus, and (4) the protecting virus de- sylvestris against challenge inoculations with a necrotiz-
pletes host metabolites and/or occupies host structures ing strain of TMV. However, Gerber and Sarkar (1989)
that are needed by the challenge virus to establish an found the same CP-minus mutant did cross protect
infection (Sherwood and Fulton, 1982; Palukaitis and Zait- against TMV in Samsun tobacco. Additionally, Zaitlin
lin, 1984; Dodds et al., 1985; Ponz and Bruening, 1986; (1976) demonstrated that a CP mutant, which does not
Sherwood, 1987a). Interestingly, several of these mecha- encapsidate TMV RNA, was still capable of conferring
nisms have been proposed to explain pathogen-derived protection against TMV. Thus, the role CP plays in confer-
resistance in transgenic plants (Fitchen and Beachy, ring cross protection remains in question.
1993). Unfortunately, the precise mechanisms and rela- Interestingly, many of the characteristics of TMV cross
tionships between cross protection and transgene-de- protection are also present in transgene-derived TMV
rived coat protein-mediated protection (CPMP) remain CPMP. These include a requirement for CP expression,
largely unknown. the ability of uncoated RNA to overcome resistance, and
Within the tobamoviruses the involvement of the viral the finding that a mutant CP incapable of forming normal
CP in cross protection has been investigated. In Nicoti- virions can still confer protection (Powell-Abel et al.,
ana sylvestris systemically infected with tobacco mosaic 1990; Nelson et al., 1987; Clark et al., 1995). These stud-
tobamovirus (TMV) only the dark green mosaic areas of ies and others have led to the hypothesis that transgene-
derived resistance is due to the inhibition of an initialthe leaves are susceptible to challenge inoculation with
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step in the virus life cycle, perhaps involving virion disas- fashion except the initial 5* PCR primer contained a muta-
tion in the TMV CP translational start codon (AUG tosembly, either directly or through a required host recep-
tor (Fitchen and Beachy, 1993). AGA). The presence of the entire CP coding sequence
in both pPVXCPTMV and pPVXNSTMV was subsequentlyIdentifying the specific mechanisms behind cross pro-
tection or CPMP has proven somewhat difficult, in part confirmed by PCR amplification and DNA sequencing.
because of the inability to rapidly test different viruses pTMVCPCGMMV was constructed from pTMVNS, a deriv-
or virus constructs for the ability to confer protection. ative of pTMV[-CP] and pSNCOO4 (Dawson et al., 1986;
Currently, transgene expression is the only method capa- Culver and Dawson, 1989b; Turpen et al., 1995). pTMVNS
ble of identifying the virus components that confer resis- is a full-length cDNA clone of TMV containing a unique
tance. However, inherent disadvantages in using BglII site engineered at the CP translational start codon,
transgenic plants, including variations between plant nt 5711. The CP of cucumber green mottle mosaic toba-
lines expressing the same construct, numbers and posi- movirus (CGMMV) was generated by reverse transcrip-
tions of integrated genes, gene silencing, and the time tion (RT) and PCR amplification (Kawasaki, 1990) of puri-
required to regenerate and test plants, make the process fied viral RNA (CGMMV virions were kindly provided by
of collecting and interpreting data related to cross protec- G. Stubbs, Vanderbilt University, Nashville, TN). The 5*-
tion mechanisms difficult. In this study, a novel cross- end PCR primer encoded a BglII site and sequences
protection system was developed using a potato X potex- covering the CP translational start codon. The 3*-end
virus (PVX) vector (Chapman et al., 1992) to express the PCR primer encoded sequences complimentary to TMV
CP open reading frame of TMV. Results demonstrate nt 6187 to 6192, including a unique NsiI site, as well as
that both TMV CP and its RNA coding sequence, when CGMMV sequences upstream of the CP translational
expressed by PVX, confer protection against subsequent stop codon. The PCR-amplified CGMMV CP ORF was
TMV challenge inoculations. However, expression of CP subsequently cut with BglII and NsiI and ligated into
provides significantly higher levels of protection than ex- similarly cut pTMVNS. The presence of the entire
pression of its coding sequence alone. Protection was CGMMV CP ORF was confirmed by PCR and sequencing.
also overcome with increased levels of challenge inocu-
lum, uncoated TMV RNA, and a TMV construct express-
Infectivity and challenge inoculationsing a distantly related tobamovirus CP. Taken together
these findings indicate that vector-expressed protection
Infectious RNA transcripts were generated frommimics both TMV cross protection and TMV CPMP.
pPVX2C2S, pPVXCPTMV, pPVXNSTMV, and pTMVCPCGMMV
as previously described (Chapman et al., 1992; TurpenMATERIALS AND METHODS
et al., 1995). Infectious RNA from PVX constructs were
Virus constructs used to inoculate Nicotiana benthamiana plants at the
three- to four-leaf stage, a host systemically infected byThe PVX vector, pPVX2C2S (Fig. 1A), is a derivative
PVX. As an additional inoculum source, virions from eachof pGC3 (Chapman et al., 1992) which contains unique
PVX construct were purified (Baulcombe et al., 1984) aftercloning sites engineered downstream of the PVX CP sub-
a single passage through N. benthamiana, and the main-genomic promoter (kindly provided by D. Baulcombe,
tenance of the inserted TMV CP ORF was confirmed bySainsbury Laboratory, Norwich, UK). In this study, the
RT-PCR using both TMV CP-specific primers and PVX-TMV CP open reading frame (ORF) was cloned into the
specific primers that flank (PVX nucleotides 5570 – 5870)EcoRV (nt 5680) and SalI sites (nt 5684) of pPVX2C2S.
the TMV CP.This permits the transcription and translation of the TMV
Infectious RNA from TMV constructs was used to inoc-CP ORF directly from within the PVX RNA genome. The
ulate Nicotiana tabacum cv Xanthi, a host systemicallyTMV CP ORF was derived from plasmid pDL3, containing
infected by TMV. Virions were purified as previously de-the entire 3* half of the TMV genome (Culver and Daw-
scribed (Gooding and Hebert, 1967) for use in subse-son, 1989a). TMV nucleotide numbering is from Goelet
quent challenge inoculations. Infectious TMV RNA waset al. (1982). The polymerase chain reaction (PCR) was
extracted from purified virions by proteinase K treatmentused to amplify a DNA fragment containing the CP ORF
in 10 mM NaCl, 10 mM MgCl2 , 20 mM Tris – HCl, pH 8.0,(nt 5711 to nt 6187) of TMV (Mullis et al., 1986). The
with 5% SDS for 1 hr at 657. RNA was extracted twice5*-end PCR primer encoded an EcoRV restriction site
with equal volumes of phenol/chloroform, precipitatedfollowed by sequences complimentary to TMV, including
with 95% EtOH, resuspended in 10 mM sodium phos-the CP translational start codon. The 3*-end PCR primer
phate buffer, pH 7.2, and immediately used as inoculum.consisted of sequences complementary to TMV, includ-
Only plants and leaves of N. benthamiana showing sys-ing the CP translational stop codon and a SalI restriction
temic PVX vector symptoms, having between 6 and 10site. The resulting PCR-amplified CP ORF fragment was
leaves, were challenge inoculated with TMV. For TMVcut with EcoRV and SalI and ligated into similarly di-
accumulation assays only the first 2 leaves to displaygested pPVX2C2S to produce pPVXCPTMV (Fig. 1A).
pPVXNSTMV (NS  no start) was constructed in a similar mosaic PVX symptoms were challenge inoculated.
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FIG. 1. PVX constructs and analysis of TMV CP expression in N. benthamiana. (A) Schematic representation of PVX2C2S, PVXNSTMV, and PVXCPTMV.
(B) Immunoblot for the detection of TMV CP. Lane 1, 15 mg of total protein extracted from TMV-infected N. tabacum tissue; lane 2, 0.1 mg of purified
TMV CP; lanes 3 through 6, 30 mg of total protein extracted from healthy (lane 3) or PVX2C2S (lane 4), PVXNSTMV (lane 5), and PVXCPTMV (lane 6)
infected N. benthamiana tissue. (C) RT-PCR amplification of PVX constructs from purified virus RNA. Lanes 1 through 5, amplification using primers
specific to the TMV CP ORF. Lane 1, PVX2C2S; lane 2, PVXCPTMV; lane 3, PVXNSTMV; lane 4, PstI-cut l DNA; lane 5, pPDL3, a positive control for
the TMV CP ORF. Lanes 6 through 9, amplification using PVX-specific primers flanking the inserted TMV CP ORF. Lane 6, plasmid PVXCPTMV, a
positive control for the inserted TMV CP ORF; lane 7, PVX2C2S; lane 8, PVXNSTMV; lane 9, PVXCPTMV.
Immunoblot and PCR analysis resulted in the rapid collapse of entire leaf sections and
were designated too numerous to count (TNTC). For the
N. benthamiana tissue systemically infected with purposes of estimating a mean, samples TNTC were
PVX2C2S, PVXCPTMV, or PVXNSTMV was extracted in 10 assigned a lesion number of 350, the upper limit of the
mM phosphate buffer, pH 7.2. Total protein concentra- local lesion assay. The standard error (SE) was deter-
tions were determined by Bradford assay (Bradford, mined only for sample times that did not contain TNTC
1976). Proteins were then separated by SDS – PAGE samples.
(Laemmli, 1970) and electrophoretically transferred to ni-
trocellulose paper. Transferred proteins were probed
RESULTS AND DISCUSSIONwith rabbit anti-TMV CP antiserum (Lehto et al., 1990),
followed by alkaline phosphatase-conjugated goat anti-
PVX expression of the TMV CP open reading framerabbit antibody (Sigma, St. Louis, MO 63178). TMV CP
was visualized by the addition of BCIP-NBT (1 – 2 mg/blot) PVX2C2S, PVXCPTMV, and PVXNSTMV all systematically
as described by Knecht and Dimond (1984). All blockings infected N. benthamiana and induced similar mild-mo-
and incubations were done in Tris-buffered saline (50 saic symptoms. Immunoblot analysis of infected tissue
mM Tris – HCl, pH 7.4, 0.2 M NaCl, and 10% w/v nonfat demonstrated that PVXCPTMV expressed TMV CP (Fig.
dry milk) for 2 hr at room temperature. RNA from purified 1B) at a level estimated to range between 90 and 480
PVX virions was extracted by treatment with proteinase ng/30 mg of extracted leaf protein as determined by com-
K as described above. Purified RNA was subjected to parison to immunoblot of known TMV CP concentrations
RT-PCR using the TMV CP and PVX flanking primers (Fig. 1; data not shown). This represents between 0.3 and
described above. 1.6% of the total extracted leaf protein. By comparison, CP
expression in transgenic plants that confer CPMP wasTMV accumulation assay
estimated at about 0.1% of the total leaf protein (Powell-
Abel et al., 1986), while CP expression was greater thanTo assay the accumulation of TMV, leaf disks weighing
approximately 0.1 g were randomly taken from challenge- 12% of the total extracted protein from protoplasts in-
fected with wild-type TMV (Paterson and Knight, 1975).inoculated leaves at various times. Each disk was
crushed in 100 ml of 10 mM sodium phosphate buffer, Thus, CP expression levels from the PVX vector were
intermediate between the levels expressed in transgenicpH 7.2, and 20 ml was used to inoculate a leaf of N.
tabacum cv Xanthi-nc, a TMV local lesion host. The num- plants and those expressed in TMV-infected tissue.
PVXNSTMV failed to express detectable levels of TMV CPber of TMV lesions appearing on Xanthi-nc tobacco was
used to determine the approximate accumulation of TMV. in immunoblot assays capable of detecting between 1
and 10 ng of TMV CP.Samples yielding lesion numbers greater than 300 to 350
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Maintenance of the CP ORF in both PVXCPTMV and the appearance of necrotic symptoms (Figs. 2 and 3).
PVXNSTMV was determined by RT-PCR analysis of virion Challenge inoculations with 5 mg of purified TMV resulted
RNA. PCR analysis using TMV CP-specific primers to in the rapid accumulation of TMV in healthy and
amplify the 400 bp TMV CP ORF fragment indicated its PVX2C2S-preinfected leaves of N. benthamiana, reach-
presence in virions isolated from tissue systemically in- ing average lesion numbers TNTC between 4 and 6 days
fected with PVXCPTMV or PVXNSTMV (Fig. 1C). Additional post-challenge inoculation, becoming necrotic and dying
PCR analysis using PVX-specific primers to amplify a by Day 6 (Fig. 3). By comparison, N. benthamiana leaves
300-bp region flanking either side of the inserted CP ORF preinfected with PVXNSTMV produced significantly fewer
also indicated the majority of amplified PVXCPTMV and TMV lesions at 2 days post-challenge inoculation, as
PVXNSTMV product maintained the TMV CP ORF (Fig. 1C). determined by t test analysis (a  0.02), and did not
However, two faint smaller bands were also amplified reach average local lesion numbers TNTC until 6 to 8
from PVXCPTMV and PVXNSTMV virion RNA. This suggests days post-challenge inoculation (Fig. 3). In contrast,
a small proportion of the PVX population has deleted the PVXCPTMV preinfected N. benthamiana leaves did not ac-
TMV CP ORF. This level of instability is consistent with cumulate significant levels of TMV until 10 days post-
the reports of Chapman et al. (1992) and demonstrates challenge inoculation. Levels of TMV accumulation in
the need to avoid repeated plant passages with these PVXCPTMV-preinfected leaves also remained low and de-
vectors. To avert the buildup of PVX populations lacking clined over time (Fig. 3). This decline is likely an artifact
the TMV CP only, transcript RNA or single passaged of the system and related to the appearance of vascular
virions were used as protecting inoculum in this study. necrosis in some of the inoculated leaf petioles. Petiole
necrosis resulted in leaf death that inhibited the further
Symptomatology of TMV challenge inoculations accumulation of virus and interfered with continued sam-
pling. Vascular necrosis also affected the later timeTMV induced a necrotic response in healthy N. ben-
points sampled from healthy and PVX2C2S- andthamiana. This necrosis appeared within 3 days postin-
PVXNSTMV-protected plants, but to a lesser extent sinceoculation as necrotic areas on the inoculated leaves.
the accumulation of TMV occurred more rapidly. TakenNecrosis spread rapidly within the vascular tissue, induc-
together, these findings demonstrate that both CP anding plant death within 5 to 7 days postinoculation. One
its RNA coding sequence can confer protection, but thatcharacteristic of the necrotic response was the bending
the protection conferred by the expression of CP isor hooking of the plant stem directly above the inoculated
greater. Interestingly, RNA-conferred resistance has notleaf due to necrosis of the vascular/support tissue (Fig.
been correlated with transgene-derived TMV CPMP2). In all cases, significant accumulations of TMV, as
determined by local lesion assay on N. tabacum cv. Xan- (Powell et al., 1990). This finding may be the combined
thi-nc, were associated with this necrosis (Fig. 3). This result of low levels of transgene-derived CP mRNA and
finding makes the appearance of necrosis an ideal the weak ability of CP RNA to confer protection.
marker for the presence of a TMV infection in N. ben- Increasing the TMV inoculum 10-fold to 50 mg/leaf
thamiana. shortened the time required for the development of ne-
N. benthamiana preinfected with PVX2C2S and subse- crotic symptoms and the accumulation of TMV in chal-
quently challenged with TMV resulted in a necrotic re- lenge-inoculated leaves (Fig. 4). Most significantly, N.
sponse that was indistinguishable from TMV-infected benthamiana leaves preinfected with PVXNSTMV did not
nonprotected healthy plants (Fig. 2). In contrast, N. ben- show a delay in TMV accumulation as observed with the
thamiana preinfected with either PVXNSTMV or PVXCPTMV 5 mg/leaf concentration of challenge inoculum, whereas
and challenged with TMV showed a delay in the develop- leaves preinfected with PVXCPTMV showed only a 2-day
ment of necrotic symptoms (Figs. 2A and 2B). For delay in the accumulation of TMV (Fig. 4). Thus, in-
PVXNSTMV preinfected plants, TMV necrosis on the inocu- creased challenge inoculum concentrations more rapidly
lated leaves appeared 5 to 7 days post-challenge inocu- overcame the conferred protection.
lation followed by systemic necrosis and stem hooking Studies involving both TMV-conferred cross protection
at 2 weeks. For PVXCPTMV-preinfected plants, TMV necro- and transgene-derived TMV CPMP have also demon-
sis on the inoculated leaves did not appear for approxi- strated the ability of increased inoculum concentrations
mately 2 to 3 weeks post-challenge inoculation with sys- to overcome protection (Cassells and Herrick, 1977; Pow-
temic necrosis appearing at 3 to 4 weeks (Figs. 2A ell-Abel et al., 1986). The levels of inoculum used to show
and 2B). significant breaking of TMV protection in tomato were at
least 10-fold higher than the inoculum level needed to
TMV accumulation in challenge-inoculated leaves
break protection in this study (Cassells and Herrick,
1977), while the inoculum levels used to break TMVThe accumulation of TMV in challenge-inoculated
CPMP in tobacco were approximately 10-fold lowerleaves was determined at various times by local lesion
(Powell-Abel et al., 1986). These findings reflect the inter-assay on N. tabacum cv. Xanthi-nc, a local lesion host
for TMV but not for PVX. TMV accumulation preceded mediate expression level of the TMV CP from the PVX
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FIG. 2. Development of TMV symptoms in N. benthamiana that were either healthy or systemically infected with PVX2C2S, PVXNSTMV, or PVXCPTMV
prior to TMV challenge inoculation. Plants are representative of six to eight used per experiment. Symptoms at (A) 2 weeks post-challenge inoculation
with 10 mg of purified TMV, (B) 3 weeks post-challenge inoculation with 10 mg of purified TMV, and (C) 1 week post-challenge inoculation with 25
mg of purified TMV RNA. The 25-mg concentration of TMV RNA was similar in infectivity to the 10 mg/plant of TMV virions used in A and B.
thamiana plants systemically infected with PVX2C2S,vector and further demonstrate the role of TMV CP in
PVXCPTMV, or PVXNSTMV were challenge inoculated withconferring high levels of protection.
infectious TMV RNA. Each leaf was inoculated with 12.5
mg of TMV RNA, a concentration that was comparableChallenge inoculation with infectious TMV RNA
in infectivity, defined as the number of TMV local lesions
One characteristic feature of TMV cross protection as produced on N. tabacum cv. Xanthi-nc, to the 5 mg of
well as TMV CPMP is the ability of unencapsidated RNA purified TMV virions used as the inoculum in Fig. 3. Infec-
to overcome the conferred resistance (Sherwood and tious RNA overcame the protection conferred by either
PVXNSTMV or PVXCPTMV, resulting in symptom develop-Fulton, 1982; Nelson et al., 1987). In this study, N. ben-
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FIG. 3. Accumulation of TMV in challenge-inoculated leaves of nonprotected healthy or PVX2C2S, PVXNSTMV, and PVXCPTMV preinfected N.
benthamiana. Each leaf was challenge inoculated with 5 mg of purified TMV virions. (A) Bars represent the average number of TMV lesions obtained
on N. tabacum cv. Xanthi-nc (TMV local lesion host) for eight samples taken randomly from four challenge-inoculated leaves. The mean { SE are
shown for Day 2. TNTC indicates that samples produced confluent lesions (300 to 350) that collapsed entire portions of the leaf. (B) Chart
displaying the number of samples testing TNTC at each day post-challenge inoculation. Local lesion data are given until the time in which all eight
challenge-inoculated leaves became necrotic.
ment and TMV accumulation in inoculated leaves being otide level and 36% homology at the amino acid level.
similar to both healthy and PVX2C2S-preinfected plants Challenge inoculations using 5 mg/leaf purified
(Figs. 2C and 5A). Thus, the PVX-vectored cross protec- TMVCPCGMMV virions resulted in no difference in the ap-
tion is not effective against unencapsidated RNA. pearance of symptoms on healthy or PVX2C2S-,
PVXNSTMV-, or PVXCPTMV-preinfected plants (data not
Challenge inoculation with a nonhomologous shown). Additionally, the accumulation of TMVCPCGMMV
tobamovirus CP at 6 days postchallenge was similar in healthy and
PVX2C2S-, PVXNSTMV-, and PVXCPTMV-preinfected leavesBy definition, cross protection or CPMP is typically only
(Fig. 5B). This finding demonstrates that the observedeffective against viruses closely related to the protecting
protection is not effective against distantly related toba-virus or gene sequence. To examine the specificity of
moviruses and is consistent with results from both non-the protection conferred by PVXNSTMV and PVXCPTMV,
transgenic and transgenic tobamovirus systems.TMVCPCGMMV, a TMV construct with the CP ORF replaced
The ability of PVX-expressed TMV CP to protectby the CP ORF of CGMMV, was used as challenge inocu-
against subsequent TMV challenge inoculations in alum. This TMV construct produces only CGMMV CP,
fashion similar to the resistance conferred in both crossforms virions, and moves systemically in N. benthamiana
protection and CPMP indicates that the vector-conferredat a rate similar to wild-type TMV. The CP ORF of CGMMV
shares 46% homology with the TMV CP ORF at the nucle- protection may be operating via similar mechanisms. In
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FIG. 4. Accumulation of TMV in challenge-inoculated leaves of nonprotected healthy or PVX2C2S-, PVXNSTMV-, and PVXCPTMV-preinfected N.
benthamiana. Each leaf was challenge inoculated with 50 mg of purified TMV virions. (A) Bars represent the average number of TMV lesions
obtained on N. tabacum cv. Xanthi-nc (TMV local lesion host) for eight samples taken randomly from four challenge-inoculated leaves. TNTC
indicates that samples produced confluent lesions (300 to 350) that collapsed entire portions of the leaf. (B) Chart displaying the number of
samples testing TNTC at each day post-challenge inoculation. Local lesion data are given until the time in which all eight challenge-inoculated
leaves became necrotic.
particular, it is clear that both CP and its RNA contribute protection as well as a method to rapidly test specifically
modified virus constructs for their ability to confer in-to protection, but that protein provides the most effective
block against the establishment of a TMV infection. The creased or novel forms of resistance prior to the produc-
tion of transgenic plants. Additionally, vectors now existdevelopment of this system should provide a useful tool
to more precisely define the mechanisms responsible for in a number virus groups (Donson et al., 1991; Dolja et
FIG. 5. Accumulation of TMV in nonprotected healthy or PVX2C2S-, PVXNSTMV-, and PVXCPTMV-preinfected N. benthamiana plants challenge
inoculated with (A) 12.5 mg/leaf purified TMV RNA or (B) 5 mg/leaf purified TMVCPCGMMV. Bars represent the average number of TMV lesions obtained
on N. tabacum cv. Xanthi-nc for eight samples taken randomly from four challenge-inoculated leaves. The mean { SE is shown for Day 2. TNTC
indicates that samples produced confluent lesions that collapsed the entire leaf.
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Gerber, M., and Sarkar, S. (1989). The coat protein of tobacco mosaical., 1992; Scholthof et al., 1993), making it possible to
virus does not play a significant role for cross-protection. J. Phytopa-develop similar systems to study the cross protection
thol. 124, 323– 331.
conferred by other virus proteins and/or sequences. Goelet, P., Lomonossoff, G. P., Butler, P. J. G., Akam, M. E., Gait, M. J.,
and Karn, J. (1982). Nucleotide sequence of tobacco mosaic virus.
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